NERV
Price
$1.99
Change
-$0.00 (-0.00%)
Updated
Jul 18, 04:44 PM (EDT)
Capitalization
13.92M
25 days until earnings call
PLRX
Price
$1.45
Change
+$0.03 (+2.11%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
87.17M
24 days until earnings call
Interact to see
Advertisement

NERV vs PLRX

Header iconNERV vs PLRX Comparison
Open Charts NERV vs PLRXBanner chart's image
Minerva Neurosciences
Price$1.99
Change-$0.00 (-0.00%)
Volume$100
Capitalization13.92M
Pliant Therapeutics
Price$1.45
Change+$0.03 (+2.11%)
Volume$7.24K
Capitalization87.17M
NERV vs PLRX Comparison Chart in %
Loading...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NERV vs. PLRX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NERV is a Hold and PLRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (NERV: $1.99 vs. PLRX: $1.42)
Brand notoriety: NERV and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NERV: 559% vs. PLRX: 86%
Market capitalization -- NERV: $13.92M vs. PLRX: $87.17M
NERV [@Biotechnology] is valued at $13.92M. PLRX’s [@Biotechnology] market capitalization is $87.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NERV’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • NERV’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, NERV is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NERV’s TA Score shows that 5 TA indicator(s) are bullish while PLRX’s TA Score has 5 bullish TA indicator(s).

  • NERV’s TA Score: 5 bullish, 4 bearish.
  • PLRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both NERV and PLRX are a good buy in the short-term.

Price Growth

NERV (@Biotechnology) experienced а +21.34% price change this week, while PLRX (@Biotechnology) price change was +1.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

NERV is expected to report earnings on Nov 10, 2025.

PLRX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($87.2M) has a higher market cap than NERV($13.9M). NERV YTD gains are higher at: -10.425 vs. PLRX (-89.218). NERV has higher annual earnings (EBITDA): 8.58M vs. PLRX (-214.08M). PLRX has more cash in the bank: 306M vs. NERV (17.3M). NERV has less debt than PLRX: NERV (0) vs PLRX (60.2M). NERV (0) and PLRX (0) have equivalent revenues.
NERVPLRXNERV / PLRX
Capitalization13.9M87.2M16%
EBITDA8.58M-214.08M-4%
Gain YTD-10.425-89.21812%
P/E Ratio2.43N/A-
Revenue00-
Total Cash17.3M306M6%
Total Debt060.2M-
FUNDAMENTALS RATINGS
NERV: Fundamental Ratings
NERV
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NERVPLRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROOOF0.270.02
+8.47%
NORTHSTAR CLEAN TECHNOLOGIES INC.
TBVPF0.36N/A
N/A
Thai Beverage Public Co., Ltd.
CHMX5.30N/A
N/A
Next-ChemX Corporation
SRAIF23.23N/A
N/A
STADLER RAIL AG
SFES0.72-0.06
-8.19%
Safeguard Scientifics, Inc.

NERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NERV has been loosely correlated with DNLI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NERV
1D Price
Change %
NERV100%
-5.46%
DNLI - NERV
34%
Loosely correlated
-2.29%
ANAB - NERV
33%
Poorly correlated
-0.67%
TCRX - NERV
32%
Poorly correlated
+6.78%
IDYA - NERV
31%
Poorly correlated
-0.27%
PLRX - NERV
31%
Poorly correlated
+5.97%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+5.97%
LXRX - PLRX
41%
Loosely correlated
+4.65%
OCUL - PLRX
41%
Loosely correlated
+1.16%
ITRM - PLRX
41%
Loosely correlated
+1.03%
SRRK - PLRX
41%
Loosely correlated
+4.16%
FHTX - PLRX
40%
Loosely correlated
+3.74%
More